PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21771726-5	2011	Among all studied HDAC inhibitors, valproic acid (VPA) and CI-994 showed prolonged effects on histone acetylation, while combination with decitabine produced the most prominent effects on caspase-8 re-expression.	tacedinaline	59-65	histone deacetylase 9	Homo sapiens	18-22	
32599645-4	2020	Here, we describe that TW9, a newly generated adduct of the BET inhibitor (+)-JQ1 and class I HDAC inhibitor CI994, is a potent dual inhibitor simultaneously targeting BET and HDAC proteins.	tacedinaline	109-114	histone deacetylase 9	Homo sapiens	94-98	
32599645-4	2020	Here, we describe that TW9, a newly generated adduct of the BET inhibitor (+)-JQ1 and class I HDAC inhibitor CI994, is a potent dual inhibitor simultaneously targeting BET and HDAC proteins.	tacedinaline	109-114	histone deacetylase 9	Homo sapiens	176-180	
25827403-2	2015	An innovative aspect of this drug delivery particle lies in the NP conjugation of a histone deacetylase (HDAC) inhibitor, CI-994 (Tacedinaline), introduced with a clickable acid-responsive prodrug during monomer synthesis, prior to polymerization.	tacedinaline	122-128	histone deacetylase 9	Homo sapiens	84-103	
25827403-2	2015	An innovative aspect of this drug delivery particle lies in the NP conjugation of a histone deacetylase (HDAC) inhibitor, CI-994 (Tacedinaline), introduced with a clickable acid-responsive prodrug during monomer synthesis, prior to polymerization.	tacedinaline	122-128	histone deacetylase 9	Homo sapiens	105-109	
25827403-2	2015	An innovative aspect of this drug delivery particle lies in the NP conjugation of a histone deacetylase (HDAC) inhibitor, CI-994 (Tacedinaline), introduced with a clickable acid-responsive prodrug during monomer synthesis, prior to polymerization.	tacedinaline	130-142	histone deacetylase 9	Homo sapiens	84-103	
25827403-2	2015	An innovative aspect of this drug delivery particle lies in the NP conjugation of a histone deacetylase (HDAC) inhibitor, CI-994 (Tacedinaline), introduced with a clickable acid-responsive prodrug during monomer synthesis, prior to polymerization.	tacedinaline	130-142	histone deacetylase 9	Homo sapiens	105-109	
18424067-6	2008	HDAC inhibitors, under clinical evaluation in the treatment of NSCLC patients, are pivanex, CI-994, vorinostat, and LBH589.	tacedinaline	92-98	histone deacetylase 9	Homo sapiens	0-4